Product NDC: | 59762-5011 |
Proprietary Name: | spironolactone |
Non Proprietary Name: | SPIRONOLACTONE |
Active Ingredient(s): | 25 mg/1 & nbsp; SPIRONOLACTONE |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 59762-5011 |
Labeler Name: | Greenstone LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA012151 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 19600121 |
Package NDC: | 59762-5011-2 |
Package Description: | 500 TABLET, FILM COATED in 1 BOTTLE (59762-5011-2) |
NDC Code | 59762-5011-2 |
Proprietary Name | spironolactone |
Package Description | 500 TABLET, FILM COATED in 1 BOTTLE (59762-5011-2) |
Product NDC | 59762-5011 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | SPIRONOLACTONE |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 19600121 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Greenstone LLC |
Substance Name | SPIRONOLACTONE |
Strength Number | 25 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |